Branford Industrial Site Sold, to Become Cannabis Growing Operation – The Wilton Bulletin
A Branford cannabis cultivation facility is being established on a former industrial site, marking growth in Connecticut's licensed cannabis market. This expansion affects product availability and regulatory compliance for clinicians and patients.…
New Cannabis Dispensary Opens On Route 22 In Somerville | Bridgewater, NJ Patch
A new cannabis dispensary Somerville has opened on Route 22, expanding retail access in New Jersey's adult-use cannabis market. This new cannabis dispensary Somerville location reflects the state's ongoing cannabis market maturation. Clinicians should…
President Biden Signs Historic Cannabis Research Bill – Ganjapreneur
President Biden's signing of historic cannabis research legislation removes federal barriers that have restricted scientific investigation of cannabis for decades. This bill enables researchers to conduct more rigorous clinical trials and epidemiological…
New Study Highlights Cannabis Compounds for Liver Protection
Recent research on cannabis compounds liver protection reveals promising effects against fatty liver disease. These compounds may modulate metabolic pathways and reduce hepatic inflammation. While preclinical, this evidence supports further study for…
North Shore Dispensary Launches in Duluth’s Lincoln Park Neighborhood
The north shore dispensary opens in Duluth’s Lincoln Park, expanding legal cannabis access in the region. This new dispensary supports Minnesota’s medical cannabis program by improving patient access. Local clinicians can now better guide patients on…
Cannabis Legalization Driving Increases in Marijuana Use Among Historically Marginalized US Adults
Cannabis use among historically marginalized adults has increased following legalization in the US. This shift reflects greater availability and reduced stigma but raises clinical concerns. Understanding cannabis use patterns in these populations is…
Study reveals cannabis compounds reduce threat of fatty liver disease | Health
Recent research highlights cannabidiol and fatty liver disease connections, showing cannabinoids may reduce liver fat and inflammation. These findings suggest potential therapeutic roles for CBD and cannabigerol. However, clinical trials are needed to…
Marijuana Status-Based Prohibition: Legal and Clinical Insights
Marijuana legal status clinical implications are critical for clinicians navigating evolving cannabis laws. Legal availability does not guarantee clinical safety or evidence-based benefits. Understanding these implications helps providers manage patient…
The Week in Weed: Regulatory Clinical Implications March 2026
This article reviews cannabis regulatory clinical implications relevant to March 2026. It highlights how evolving legal frameworks affect clinical practice and patient safety. Clinicians must navigate these changes to optimize cannabis medicine use.
From Billion-Dollar Hemp Drinks to FDA Cease-and-Desist Letters: The Cannabis Industry’s Reckoning
Cannabis industry regulatory enforcement is intensifying as the FDA issues cease-and-desist letters to hemp beverage companies. These actions address unsubstantiated claims about cannabinoid products. Clinicians must navigate this evolving landscape to…
